智飞生物：公司及全资子公司取得发明专利证书

Group 1 - The core point of the news is that Zhifei Biological has obtained a patent for a vaccine that can prevent Helicobacter pylori infection, which may enhance its product portfolio and market position [1] - Zhifei Biological's revenue composition for the year 2024 is projected to be 99.14% from biological products and 0.86% from other businesses, indicating a strong focus on its core offerings [1] - As of the latest report, Zhifei Biological has a market capitalization of 50.2 billion yuan, reflecting its significant presence in the biotechnology sector [2]